<DOC>
	<DOCNO>NCT00942994</DOCNO>
	<brief_summary>The purpose study compare combination aliskiren , amlodipine Hydrochlorothiazide ( HCTZ ) versus combination aliskiren amlodipine therapy minority Stage 2 hypertensive patient .</brief_summary>
	<brief_title>Aliskiren/Amlodipine/Hydrochlorothiazide ( HCTZ ) Versus Aliskiren/Amlodipine US Minority Patients With Stage II Systolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients newly diagnose history hypertension , eligible able participate study , give write informed consent assessment perform . Men woman 18 year old minority background ; selfidentified . Patients stage 2 hypertension define MSSBP ≥160 mmHg &lt; 200 mmHg Visit 5 ( randomization ) . Patients MSDBP ≥110 mmHg and/or MSSBP ≥200 mmHg measure office cuff visit . Patients 4 antihypertensive medication . Patients uncontrolled hypertension ( MSSBP &gt; 180 mmHg ) take 1 antihypertensive medication Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>HCTZ</keyword>
	<keyword>Systolic blood pressure</keyword>
	<keyword>Diastolic blood pressure</keyword>
	<keyword>Stage II</keyword>
	<keyword>Combination</keyword>
</DOC>